Live Breaking News & Updates on Insider Activity At Catalyst Pharmaceuticals

Stay updated with breaking news from Insider activity at catalyst pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Brian Elsbernd , Sherbrooke Park Advisers , Financial Services Group Inc , Cantor Fitzgerald , News Ratings For Catalyst Pharmaceuticals Daily , Catalyst Pharmaceuticals Stock Performance , Nisa Investment Advisors , Parkside Financial Bank , Insider Activity At Catalyst Pharmaceuticals , Securities Exchange Commission , Catalyst Pharmaceuticals Inc , Holdings Channel , Catalyst Pharmaceuticals , Quarter For Catalyst Pharmaceuticals , Summit Global Investments , Free Report , Global Investment , Financial Bank , Investment Advisors , Park Advisers , Services Group , Centerbook Partners , Book Partners , Get Free Report , Exchange Commission ,

Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Bank of America

Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Bank of America
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Davids Tierney , Catalyst Pharmaceuticals Company Profile , Insider Activity At Catalyst Pharmaceuticals , Parkside Financial Bank , Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Stock Performance , Visionpoint Advisory Group , News Ratings For Catalyst Pharmaceuticals Daily , Covestor Ltd , Cantor Fitzgerald , Advisory Services Network , Hedge Funds Weigh In On Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Inc , Free Report , Director David , Services Network , Financial Bank , Get Free Report , Catalyst Pharmaceuticals Daily ,

Catalyst Pharmaceuticals (NASDAQ:CPRX) Shares Gap Down to $17.11

Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $17.11, but opened at $14.58. Catalyst Pharmaceuticals shares last traded at $14.81, with a volume of 1,673,229 shares. Analyst Ratings Changes CPRX has been the topic of a number of research […] ....

United States , Alicia Grande , Davids Tierney , Catalyst Pharmaceuticals Inc , Securities Exchange Commission , News Ratings For Catalyst Pharmaceuticals Daily , Catalyst Pharmaceuticals Stock Down , Catalyst Pharmaceuticals Company Profile , Denali Advisors , Catalyst Pharmaceuticals , Insider Activity At Catalyst Pharmaceuticals , Barclays Plc , Get Free Report , Pharmaceuticals Stock Down , Exchange Commission , Director David , Strs Ohio , Catalyst Pharmaceuticals Daily , Nasdaq Cprx ,

Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright

Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United States , Patrickj Mcenany , Piper Sandler , Catalyst Pharmaceuticals , Advisory Services , Catalyst Pharmaceuticals Stock , Catalyst Pharmaceuticals Inc , Navellier Associates Inc , Insider Activity At Catalyst Pharmaceuticals , Cantor Fitzgerald , Jupiter Asset Management Ltd , News Ratings For Catalyst Pharmaceuticals Daily , Get Free Report , Asset Management , Catalyst Pharmaceuticals Daily ,

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by O Neil Global Advisors Inc.

O Neil Global Advisors Inc. lifted its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 18.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,343 shares of the biopharmaceutical company’s stock after purchasing an additional 4,505 shares during the period. […] ....

United States , Hong Kong , Patrickj Mcenany , Piper Sandler , Davids Tierney , Cantor Fitzgerald , Investment Advisers , Covestor Ltd , O Neil Global Advisors Inc , Securities Exchange Commission , Exchange Commission , Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Stock Performance , Insider Activity At Catalyst Pharmaceuticals , Hong Kong Ltd , News Ratings For Catalyst Pharmaceuticals Daily , Oneil Global Advisors Inc , Catalyst Pharmaceuticals Company Profile , Catalyst Pharmaceuticals Inc , Quarter For Catalyst Pharmaceuticals , Get Rating , Neil Global Advisors , Kong Ltd , Director David , Truist Financial , Visit Holdingschannel ,